MPH Health Care AG (93M1.DE)

EUR 23.6

(1.72%)

EBITDA Summary of MPH Health Care AG

MPH Health Care AG's latest annual EBITDA in 2023 was 33.31 Million EUR , down -2.66% from previous year.
MPH Health Care AG's latest quarterly EBITDA in 2024 Q2 was 83.74 Million EUR , down 0.0% from previous quarter.
MPH Health Care AG reported an annual EBITDA of 29.67 Million EUR in 2022, up 426.8% from previous year.
MPH Health Care AG reported an annual EBITDA of -9.05 Million EUR in 2021, up 87.25% from previous year.
MPH Health Care AG reported a quarterly EBITDA of N/A for 2023 FY, down -2.66% from previous quarter.
MPH Health Care AG reported a quarterly EBITDA of 46.8 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of MPH Health Care AG (2023 - 2009)

Historical Annual EBITDA of MPH Health Care AG (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	33.31 Million EUR	-2.66%
2022	29.67 Million EUR	426.8%
2021	-9.05 Million EUR	87.25%
2020	-70.99 Million EUR	-712.78%
2019	40.29 Million EUR	-73.53%
2018	37.68 Million EUR	32.32%
2017	33.08 Million EUR	137.8%
2016	79.36 Million EUR	-0.95%
2015	14.04 Million EUR	10.23%
2014	12.74 Million EUR	-10.3%
2013	14.2 Million EUR	-38.72%
2012	23.11 Million EUR	110.53%
2011	11.01 Million EUR	3.44%
2010	10.64 Million EUR	66.76%
2009	6.38 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	83.74 Million EUR	0.0%
2023 FY	- EUR	-2.66%
2023 Q4	46.8 Million EUR	0.0%
2023 Q2	-15.58 Million EUR	0.0%
2022 Q4	66.07 Million EUR	0.0%
2022 FY	- EUR	426.8%
2022 Q2	-541.06 Thousand EUR	0.0%
2021 Q2	330.18 Thousand EUR	0.0%
2021 FY	- EUR	87.25%
2021 Q4	-562.83 Thousand EUR	0.0%
2020 Q2	-525.51 Thousand EUR	0.0%
2020 Q4	-545.76 Thousand EUR	0.0%
2020 FY	- EUR	-712.78%
2019 Q2	-18.4 Million EUR	0.0%
2019 FY	- EUR	-73.53%
2019 Q4	393.76 Thousand EUR	0.0%
2018 Q4	-13.57 Million EUR	0.0%
2018 FY	- EUR	32.32%
2018 Q2	57.34 Million EUR	0.0%
2017 Q2	7.09 Million EUR	0.0%
2017 FY	- EUR	137.8%
2017 Q4	25.98 Million EUR	0.0%
2016 Q4	15.4 Million EUR	0.0%
2016 FY	- EUR	-0.95%
2016 Q2	-1.49 Million EUR	0.0%
2015 Q4	18.02 Million EUR	0.0%
2015 Q2	5.99 Million EUR	0.0%
2015 FY	- EUR	10.23%
2014 FY	- EUR	-10.3%
2014 Q2	7.07 Million EUR	0.0%
2014 Q4	5.66 Million EUR	0.0%
2013 FY	- EUR	-38.72%
2013 Q4	7.71 Million EUR	0.0%
2013 Q2	6.49 Million EUR	0.0%
2012 Q4	2.54 Million EUR	0.0%
2012 Q2	5.5 Million EUR	-0.0%
2012 Q1	5.5 Million EUR	0.0%
2012 FY	- EUR	110.53%
2012 Q3	2.54 Million EUR	-53.66%
2011 FY	- EUR	3.44%
2010 FY	- EUR	66.76%
2009 FY	- EUR	0.0%

Peer EBITDA Comparison of MPH Health Care AG

Name	EBITDA	EBITDA Difference
Apontis Pharma AG	-12.94 Million EUR	357.423%
Dermapharm Holding SE	277.29 Million EUR	87.986%
Evotec SE	7.82 Million EUR	-325.846%
MERCK Kommanditgesellschaft auf Aktien	5.52 Billion EUR	99.397%
PharmaSGP Holding SE	35.86 Million EUR	7.121%
SynBiotic SE	-7.12 Million EUR	567.722%